UNH vs MRK
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | MRK |
|---|---|---|
| Price | $427.89 | $128.66 |
| Market cap | $388.59B | $317.77B |
| P/E ratio | 32.3 | 36.2 |
| ROE | 12.18% | 18.94% |
| Profit margin | 2.68% | 13.59% |
| Revenue growth | 2.00% | 4.90% |
| Dividend yield | 2.17% | 2.64% |
| Beta | 0.65 | 0.22 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs MRK in plain English
- UNH is the bigger company — about 1.2× the market cap of MRK.
- UNH is cheaper on earnings (P/E 32.3 vs 36.2).
- MRK earns a higher return on equity (19% vs 12%).
- MRK is growing revenue faster (5% vs 2%).
- MRK has the higher dividend yield (2.64% vs 2.17%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.